Is NuScale Power Stock a Buy Now?

NuScale Power (SMR) shares have surged 250% over the past year, reflecting renewed market interest in small modular reactors (SMRs) amidst growing energy demand from AI and electrification. While NuScale is the first and only company with NRC approval for its SMR design, it remains a pre-revenue startup with no commercial orders, a history of project cancellations due to cost overruns, and significant negative free cash flow ($98M LTM) requiring ongoing capital raises and shareholder dilution. At an $11 billion market capitalization, the company faces high commercialization risk, with its current valuation pricing in substantial future growth despite the unproven viability and long development timelines for its technology.

Analysis

NuScale Power Corporation (SMR) has experienced a 250% surge in its stock price over the last year, driven by a favorable macro environment where AI and electrification are renewing interest in nuclear energy. The company holds a distinct regulatory advantage as the first and only entity with a small modular reactor (SMR) design approved by the U.S. Nuclear Regulatory Commission. However, significant commercial and financial risks undermine this position. NuScale remains essentially a pre-revenue company, as its $49 million in trailing-twelve-month revenue stems from a feasibility study, not its core product. A critical red flag is the 2023 cancellation of a key project with a Utah utility due to cost overruns and delays, raising serious questions about the commercial viability of its SMR technology. Financially, the company exhibits a high cash burn rate, with a negative free cash flow of $98 million over the last year, necessitating continuous capital raises that result in shareholder dilution. At an $11 billion market capitalization, the stock's valuation appears to have priced in substantial future success, despite the absence of any firm customer orders and a history of execution challenges.

Key Decisions for Investors

• Given the $11 billion valuation for a pre-revenue company with unproven commercial viability, the current risk-reward profile is unfavorable, and investors should exercise extreme caution.
• The primary catalyst to monitor is the signing of a first firm commercial contract, which management hopes to secure by the end of 2025; this would be a critical de-risking event.
• Investors must factor in the high probability of continued shareholder dilution, as the company's significant negative free cash flow will likely necessitate further capital market financing to fund operations.